topiroxostat

DRUG2 trials

Sponsors

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fuji Yakuhin Co., Ltd.

Conditions

Hyperuricemiatype 2 diabetes mellitus, hyperuricemia

Phase 2

Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types)

CompletedNCT02837198

Fuji Yakuhin Co., Ltd.Hyperuricemia

Start: 2016-07-31End: 2018-03-31Updated: 2018-08-21

Unknown Phase

Effect of topiroxostat on diabetic nephropathy in patients with type 2 diabetes mellitus

Active, not recruitingJPRN-UMIN000038238

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu Universitytype 2 diabetes mellitus, hyperuricemia

Start: 2019-10-11Target: 20Updated: 2026-06-29

Related Papers

The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor.

2019-11-168 citations